Q3 2024 Holdings
Filed 2024-11-14 | 24 holdings | $961.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $275.9M | 2,697,267 | 28.7% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $173.9M | 10,473,913 | 18.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $88.2M | 1,795,735 | 9.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $82.5M | 3,013,423 | 8.6% |
| Savara Inc(SVRA) | COM | 805111101 | $61.8M | 14,565,457 | 6.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $61.2M | 3,303,381 | 6.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $50.0M | 8,449,748 | 5.2% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $28.1M | 4,034,582 | 2.9% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $20.9M | 2,712,008 | 2.2% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $16.5M | 3,368,370 | 1.7% |
| Mersana Therapeutics Inc | COM | 59045L106 | $16.4M | 8,663,673 | 1.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $13.0M | 2,760,888 | 1.4% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $11.3M | 16,915,784 | 1.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $9.3M | 5,410,361 | 1.0% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $8.3M | 2,485,638 | 0.9% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $7.6M | 703,080 | 0.8% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $7.5M | 8,434,560 | 0.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $6.3M | 1,111,910 | 0.7% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $5.9M | 2,750,151 | 0.6% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $5.7M | 2,000,000 | 0.6% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $4.7M | 2,693,380 | 0.5% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $3.6M | 4,566,817 | 0.4% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $1.8M | 1,799,595 | 0.2% |
| Newamsterdam Pharma Company | *W EXP 99/99/999 | N62509117 | $700.0K | 100,000 | 0.1% |